Literature DB >> 9566639

Increased biochemical markers of bone formation and resorption in primary hyperparathyroidism with special reference to patients with mild disease.

S Valdemarsson1, B Lindergård, S Tibblin, A Bergenfelz.   

Abstract

OBJECTIVES: To evaluate the impact on bone turnover of primary hyperparathyroidism (pHPT) with special reference to patients with mild pHPT, using biochemical markers of bone formation and resorption.
DESIGN: A longitudinal study of patients with pHPT before and one year after surgical treatment.
SETTING: The Departments of Internal Medicine and Surgery, Lund University Hospital.
SUBJECTS: Forty consecutive patients with pHPT. Thirty of these patients had mild pHPT and are reported separately. Data on bone mineral was also compared to a reference population. INTERVENTION: All patients were operated upon and restudied one year later. MAIN OUTCOME MEASURES: Bone resorption and formation was studied by means of the serum concentrations of the telopeptide of the carboxyterminal region of type 1 collagen (ICTP) and of alkaline phosphatase (ALP), osteocalcin and the carboxyterminal propeptide of type 1 procollagen (PICP), respectively. Bone density was measured at the distal radius by single photon absorptiometry (SPA).
RESULTS: Bone formation markers consistently decreased after parathyroid surgery: ALP from 3.51 +/- 0.23 to 2.94 +/- 0.21 microkat L(-1) (P < 0.05), osteocalcin from 6.15 +/- 0.53 to 2.89 +/- 0.23 microg L(-1) (P < 0.001) and PICP from 126.4 +/- 10.9 to 96.0 +/- 6.5 microg L(-1) (P < 0.001). In parallel, the ICTP concentration, reflecting bone resorption, decreased from 5.10 +/- 0.54 to 3.94 +/- 0.34 microg L(-1) (P < 0.001). There was not any significant change in distal radius bone mineral 1 one year after surgery. In the subgroup of patients classified as mild pHPT, a significant decrease was noted for osteocalcin, PICP and for ICTP but not for ALP, without significant changes in variables reflecting distal radius bone mineral content. Glomerular filtration rate was inversely correlated to serum levels of intact PTH, ionized calcium, alkaline phosphatase, osteocalcin and ICTP and directly correlated to the 1.25-dihydroxy-vitamin D concentrations.
CONCLUSIONS: pHPT is associated with substantial changes in circulating levels of biochemical markers of bone formation and resorption. These findings are also present in patients with mild pHPT. Renal function should be considered in the evaluation of the impact of pHPT on bone turnover.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9566639     DOI: 10.1046/j.1365-2796.1998.00241.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  10 in total

1.  Polymorphisms of the vitamin D receptor and their effect on bone mass density in patients with normocalcemic hyperparathyroidism.

Authors:  Jose Luis Perez Castrillón; Gonzalo Díaz-Soto; Olatz Izaola Jauregui; Enrique Romero; Daniel de Luis Román
Journal:  Endocrine       Date:  2015-04-21       Impact factor: 3.633

2.  The usefulness of high pre-operative levels of serum type I collagen bone markers for the prediction of changes in bone mineral density after parathyroidectomy.

Authors:  S Alonso; E Ferrero; M Donat; G Martínez; C Vargas; M Hidalgo; E Moreno
Journal:  J Endocrinol Invest       Date:  2011-09-23       Impact factor: 4.256

3.  Short-term effects of surgery in post-menopausal patients with primary hyperparathyroidism and normal bone turnover.

Authors:  V Carnevale; M T Pacitti; M Pileri; F Paglia; A Scillitani; S Dionisi; P Caravella; E Romagnoli; S Minisola
Journal:  J Endocrinol Invest       Date:  2001-09       Impact factor: 4.256

4.  Changes in bone turnover markers in primary hyperparathyroidism and response to surgery.

Authors:  P Rajeev; A Movseysan; A Baharani
Journal:  Ann R Coll Surg Engl       Date:  2017-09       Impact factor: 1.891

Review 5.  Bone turnover markers in primary hyperparathyroidism.

Authors:  Aline G Costa; John P Bilezikian
Journal:  J Clin Densitom       Date:  2013 Jan-Mar       Impact factor: 2.617

Review 6.  Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

Authors:  Shonni J Silverberg; E Michael Lewiecki; Leif Mosekilde; Munro Peacock; Mishaela R Rubin
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

Review 7.  Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus.

Authors:  A A Khan; D A Hanley; R Rizzoli; J Bollerslev; J E M Young; L Rejnmark; R Thakker; P D'Amour; T Paul; S Van Uum; M Zakaria Shrayyef; D Goltzman; S Kaiser; N E Cusano; R Bouillon; L Mosekilde; A W Kung; S D Rao; S K Bhadada; B L Clarke; J Liu; Q Duh; E Michael Lewiecki; F Bandeira; R Eastell; C Marcocci; S J Silverberg; R Udelsman; K Shawn Davison; J T Potts; M L Brandi; J P Bilezikian
Journal:  Osteoporos Int       Date:  2016-09-09       Impact factor: 4.507

Review 8.  Contemporary Medical Management of Primary Hyperparathyroidism: A Systematic Review.

Authors:  Julius Simoni Leere; Jesper Karmisholt; Maciej Robaczyk; Peter Vestergaard
Journal:  Front Endocrinol (Lausanne)       Date:  2017-04-20       Impact factor: 5.555

9.  Associations between trabecular bone score and biochemistry in surgically vs conservatively treated outpatients with primary hyperparathyroidism: A retrospective cohort study.

Authors:  Julius Simoni Leere; Christian Kruse; Maciej Robaczyk; Jesper Karmisholt; Peter Vestergaard
Journal:  Bone Rep       Date:  2018-08-09

10.  Disrupted tubular parathyroid hormone/parathyroid hormone receptor signaling and damaged tubular cell viability possibly trigger postsurgical kidney injury in patients with advanced hyperparathyroidism.

Authors:  Tetsuhiko Sato; Yamato Kikkawa; Suguru Yamamoto; Yusuke Tanaka; Junichiro J Kazama; Yoshihiro Tominaga; Toshihiro Ichimori; Manabu Okada; Takahisa Hiramitsu; Masafumi Fukagawa
Journal:  Clin Kidney J       Date:  2019-01-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.